Pharmacodynamic response to HER2/CD3 bispecific antibody (HER2-TDB): evidence of T-cell recruitment and further rationale for combination treatment with anti-PD-L1

被引：0
|
作者：
Li, Ji
Hristopoulos, Maria
Clark, Robyn
Johnston, Jennifer
Slaga, Dion
Wang, Bu-Er
Cubas, Rafael
Totpal, Klara
Junttila, Melissa R.
Junttila, Teemu T.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1486
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1486
引用
收藏
页数：3
相关论文
共 50 条
  • [1] HER2 T cell dependent bispecific antibody (HER2-TDB) for treatment of HER2 positive breast cancer
    Junttila, Teemu T.
    Li, Ji
    Johnston, Jennifer
    Hristopoulos, Maria
    Clark, Robyn
    Ellerman, Diego
    Wang, Bu-Er
    Li, Yijin
    Mathieu, Mary
    Li, Guangmin
    Young, Judy
    Luis, Elizabeth
    Phillips, Gail Lewis
    Stefanich, Eric
    Spiess, Cristoph
    Polson, Andrew
    Irving, Bryan
    Scheer, Justin M.
    Junttila, Melissa R.
    Dennis, Mark S.
    Kelley, Robert
    Totpal, Klara
    Ebens, Allen
    CANCER RESEARCH, 2015, 75
  • [2] Nonclinical Safety Profile of Anti-HER2/CD3 T-Cell-Dependent Bispecific (TDB) Antibodies
    Staflin, K.
    Schutt, L.
    Junttila, T.
    De Zafra, C.
    Katavolos, P.
    Dybdal, N.
    Totpal, K.
    Li, J.
    Hristopoulos, M.
    Clark, R.
    Ybarra, R.
    Junttila, M.
    Slaga, D.
    Johnston, J.
    Dennis, M.
    Mathieu, M.
    Chen, X.
    Ellerman, D.
    Zhong, F.
    Clark, V.
    Shelton, A.
    Prell, R.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (01) : 43 - 43
  • [3] IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody
    Li, Ji
    Ybarra, Ryan
    Mak, Judy
    Herault, Aurelie
    De Almeida, Patricia
    Arrazate, Alfonso
    Ziai, James
    Totpal, Klara
    Junttila, Melissa R.
    Walsh, Kevin B.
    Junttila, Teemu T.
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6447 - 6458
  • [4] Microenvironment-responsive anti-PD-L1 x CD3 bispecific T-cell engager for solid tumor immunotherapy
    Liu, Dingkang
    Bao, Lichen
    Zhu, Haichao
    Yue, Yali
    Tian, Jing
    Gao, Xiangdong
    Yin, Jun
    JOURNAL OF CONTROLLED RELEASE, 2023, 354 : 606 - 614
  • [5] Preclinical InVivo Data Integrated in a Modeling Network Informs a Refined Clinical Strategy for a CD3 T-Cell Bispecific in Combination with Anti-PD-L1
    Sanchez, Javier
    Nicolini, Valeria
    Fahrni, Linda
    Waldhauer, Inja
    Walz, Antje-Christine
    Jamois, Candice
    Fowler, Stephen
    Simon, Silke
    Klein, Christian
    Umana, Pablo
    Friberg, Lena
    Frances, Nicolas
    AAPS JOURNAL, 2022, 24 (06):
  • [6] Preclinical InVivo Data Integrated in a Modeling Network Informs a Refined Clinical Strategy for a CD3 T-Cell Bispecific in Combination with Anti-PD-L1
    Javier Sánchez
    Valeria Nicolini
    Linda Fahrni
    Inja Waldhauer
    Antje-Christine Walz
    Candice Jamois
    Stephen Fowler
    Silke Simon
    Christian Klein
    Pablo Umaña
    Lena E. Friberg
    Nicolas Frances
    The AAPS Journal, 24
  • [7] BISPECIFIC HER2 X CD3 ANTIBODIES ENHANCE T-CELL CYTOTOXICITY IN-VITRO AND LOCALIZE TO HER2-OVEREXPRESSING XENOGRAFTS IN NUDE-MICE
    SHALABY, MR
    CARTER, P
    MANEVAL, D
    GILTINAN, D
    KOTTS, C
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 74 (02): : 185 - 192
  • [8] Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors
    Cugnetti, Ana Paula
    Liu, Haizhen
    McNeeley, Patricia
    Wheeler, Christina
    Lucas, Matthew
    Xing, Charles
    Joyner, Solmarie
    Johnson, Kyrie
    Woodard, Kathryn
    Zhou, Wei
    Chang, Cathy
    Frey, Gerhard
    Boyle, William J.
    Short, Jay M.
    CANCER RESEARCH, 2023, 83 (07)
  • [9] PRELIMINARY SAFETY, TOLERABILITY AND EFFICACY RESULTS OF KN026 (A HER2-TARGETED BISPECIFIC ANTIBODY) IN COMBINATION WITH KN046 (AN ANTI-PD-L1/CTLA-4 BISPECIFIC ANTIBODY) IN PATIENTS (PTS) WITH HER2 ABERRATED SOLID TUMORS
    Gong, Jifang
    Dong, Zhi
    Liu, Dan
    Xu, June
    Yang, Jing
    Yang, Yue
    Qi, Yakun
    Men, Jie
    Kong, Paul
    Xu, Ting
    Shen, Lin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A207 - A207
  • [10] Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig™ for Preclinical Screening of HER2/CD3 T-Cell Engagers
    Koga, Hikaru
    Kuroi, Haruka
    Hirano, Rena
    Hirayama, Hiroyuki
    Nabuchi, Yoshiaki
    Kuramochi, Taichi
    ANTIBODIES, 2024, 13 (01)
12345